May 05, 2021
When clinical endpoints are subjective, image-based or complex to assess or the study is geographically broad, researchers of new drugs and devices may find it difficult to demonstrate acceptable safety results to regulatory authorities. Traditional manual, paper-based approaches to CEC management place significant time, cost, and resource burdens on organizations - and are prone to errors, bias and regulatory issues. Today’s web-based adjudication systems offer advantages that inefficient paper-based processes cannot. Learn from the experts about:
- How technology can transform clinical endpoint adjudication
- The keys to successful implementation
- The must-haves when selecting the right solution
- How it fits into the regulatory landscape